Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Doctor-prescribed compounded Tirzepatide dual GLP-1 & GIP agonist therapy for stronger appetite control and meaningful weight loss with once-weekly injections
41,42 Although humans can excrete small amounts of mercury in urine or feces as well as via exhalation or sweating, they lack an active robust mechanism for mercury excretion, allowing levels to accumulate with chronic exposure
Contact your GP or NHS 111 for persistent nausea, injection-site infection, or any other concerning symptoms, and bring the vial and packaging with you
Monthly growth rates were 83.9% for OZEMPIC, 119.2% for WEGOVY , 84.8% for RYBELSUS, 12.9% for ADLYXIN, 78.8% for TRULICITY, and 254.3% for MOUNJARO
This promotes faster healing and reduces inflammation
Optimal results require: Adherence to a reduced-calorie diet Regular physical activity (150+ minutes weekly of moderate intensity) Behavioural support and lifestyle modification Ongoing medical supervision Weight regain commonly occurs following medication discontinuation, highlighting the chronic nature of obesity management
US$ 20.14
US$ 21.11
US$ 29.50
US$ 21.02
US$ 23.80
US$ 21.68
US$ 29.49
US$ 29.19
US$ 28.88
US$ 23.20
